[1] 陈星月,陈栋,陈春慧,等.中国创伤性脊髓损伤流行病学和疾病经济负担的系统评价[J].中国循证医学杂志,2018,18(2):143-150.
[2] 樊保佑,冯世庆,陈琳,等.脊髓损伤神经修复临床治疗指南(IANR/CANR 2019年版)[J].西部医学,2020,32(6):790-802.
[3] LI T, XIA M, GAO Y, et al. Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther. 2015;15(9):1293-1306.
[4] WANG H, QIU X, NI P, et al. Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats. Int J Mol Med. 2014;33(2):263-270.
[5] JADAD A, MOORE R, CARROLL D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
[6] 曾宪涛,刘慧,陈曦,冷卫东.Meta分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志,2012,4(4):297-299.
[7] 曾宪涛,冷卫东,李胜,等.如何正确理解及使用GRADE系统[J].中国循证医学杂志,2011,11(9):985-990.
[8] DENG W, MA K, LIANG B, et al. Collagen scaffold combined with human umbilical cord-mesenchymal stem cells transplantation for acute complete spinal cord injury. Neural Regen Res. 2020;15(9):1686-1700.
[9] 张陆,刘志昂,姜岩,等.脐带间充质干细胞移植治疗急性脊髓损伤的临床价值[J].中国脊柱脊髓杂志, 2019,29(3):254-260.
[10] 张赞,代广辉,刘学彬,等.脐带间充质干细胞移植治疗脊髓损伤疗效观察[J].中华实用诊断与治疗杂志,2015,29(5):478-480.
[11] 徐远红,王俊华,李海峰,等.脐带间充质干细胞移植联合综合康复训练对脊髓损伤患者神经功能及功能独立性的影响[J].中国康复医学杂志,2015,30(8):828-830.
[12] CHENG H, LIU X, HUA R, et al. Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury. J Transl Med. 2014;12:253.
[13] DAI G, LIU X, ZHANG Z, et al. Comparative analysis of curative effect of CT-guided stem cell transplantation and open surgical transplantation for sequelae of spinal cord injury. J Transl Med. 2013;11:315.
[14] 张效北,李江涛,赵和泰,等.间质干细胞治疗脊髓损伤的临床分析[J].亚太传统医药,2012,8(3):116-117.
[15] 李脉.干细胞移植治疗脊髓损伤的临床研究[D].昆明:昆明医科大学,2012.
[16] 郭钢花,申利坊,李哲.脐血间充质干细胞治疗脊髓损伤临床研究[J].中国实用医刊,2012,39(10):58-60.
[17] ALBU S, KUMRU H, COLL R, et al. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. Cytotherapy. 2021;23(2):146-156.
[18] KUMAR R, LIM J, MEKARY R, et al. Traumatic spinal injury: global epidemiology and worldwide volume. World Neurosurg. 2018; 113:e345-e363.
[19] JAZAYERI S, BEYGI S, SHOKRANEH F, et al. Incidence of traumatic spinal cord injury worldwide: a systematic review. Eur Spine J. 2015;24(5):905-918.
[20] O’SHEA T, BURDA J, SOFRONIEW M. Cell biology of spinal cord injury and repair. J Clin Invest. 2017;127(9):3259-3270.
[21] 樊洪,郝定均.急性脊髓损伤治疗的研究进展[J].中华创伤杂志,2019,35(4):340-347.
[22] MUKHAMEDSHINA Y, GRACHEVA O, MUKHUTDINOVA D, et al. Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury. Neural Regen Res. 2019;14(2):227-237.
[23] 巫丹,尹宇.人脐带间充质干细胞治疗不同疾病的研究进展[J]. 中国比较医学杂志, 2020,30(8):125-130.
[24] CORRAO S, LA ROCCA G, LO IACONO M, et al. Umbilical cord revisited: from Wharton’s jelly myofibroblasts to mesenchymal stem cells. Histol Histopathol. 2013;28(10):1235-1244.
[25] LI C, ZHENG Z, SU X, et al. Activation of the extracellular signal-regulated kinase signaling is critical for human umbilical cord mesenchymal stem cell osteogenic differentiation. Biomed Res Int. 2016;2016:3764372.
[26] DE LA FUENTE A, MATEOS J, LESENDE-RODRÍGUEZ I, et al. Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells. Mol Cell Proteomics. 2012;11(2):M111.010496.
[27] SABEN J, THAKALI K, LINDSEY F, et al. Distinct adipogenic differentiation phenotypes of human umbilical cord mesenchymal cells dependent on adipogenic conditions. Exp Biol Med (Maywood). 2014;239(10):1340-1351.
[28] JIANG L, WANG Y, PAN F, et al. Synergistic effect of bioactive lipid and condition medium on cardiac differentiation of human mesenchymal stem cells from different tissues. Cell Biochem Funct. 2016;34(3):163-172.
[29] NAN C, SHI Y, ZHAO Z, et al. Monosialoteterahexosyl ganglioside induces the differentiation of human umbilical cord-derived mesenchymal stem cells into neuron-like cells. Int J Mol Med. 2015;36(4):1057-1062.
[30] YANG Y, CAO TT, TIAN ZM, et al. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study. Exp Cell Res. 2020;395(2):112184.
[31] LI C, CHEN X, QIAO S, et al. Effects of Wharton’s jelly cells of the human umbilical cord on acute spinal cord injury in rats, and expression of interleukin-1β and nerve growth factor in spinal cord tissues. Artif Cells Nanomed Biotechnol. 2016;44(5):1254-1258.
[32] 张勇,马迅,孙麟,等.人脐带间充质干细胞来源外泌体减轻大鼠脊髓星形胶质细胞氧糖剥夺/复氧损伤所致的水肿[J].中国组织工程研究,2019,23(25):4011-4017.
[33] XIAO Z, TANG F, ZHAO Y, et al. Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with neuroregen scaffolds and mesenchymal stem cells. Cell Transplant. 2018;27(6):907-915.
[34] LIU J, HAN D, WANG Z, et al. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells. Cytotherapy. 2013;15(2):185-191.
[35] 王培申,刘学彬,伊龙,等.脐带间充质干细胞鞘内移植治疗不完全性颈髓损伤的疗效和安全性[J].武警医学,2015,26(3):282-285.
|